Humana (NYSE:HUM) Given New $495.00 Price Target at Cantor Fitzgerald

Posted by Francis Steltz on Nov 9th, 2026

Humana (NYSE:HUM – Get Free Report) had its price target increased by equities researchers at Cantor Fitzgerald from $460.00 to $495.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage presently has an “overweight” rating on the insurance provider’s stock. Cantor Fitzgerald‘s price target would indicate a potential upside of 14.40% from the stock’s previous close.

A number of other research analysts also recently commented on HUM. Weiss Ratings upgraded Humana from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, August 14th. JPMorgan Chase & Co. increased their target price on Humana from $316.00 to $393.00 and gave the stock a “neutral” rating in a research report on Monday, August 10th. Citigroup started coverage on Humana in a research note on Friday, October 9th. They issued a “buy” rating on the stock. Morgan Stanley raised shares of Humana from an “underweight” rating to an “overweight” rating in a report on Friday, October 9th. Finally, UBS Group boosted their price target on shares of Humana from $405.00 to $495.00 and gave the company a “neutral” rating in a report on Monday, October 12th. Twenty-one investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $460.48.

View Our Latest Stock Analysis on HUM

Humana Stock Performance

Shares of NYSE HUM opened at $432.69 on Monday. The company has a quick ratio of 1.74, a current ratio of 1.65 and a debt-to-equity ratio of 0.61. The firm’s 50-day moving average price is $403.96 and its two-hundred day moving average price is $312.27. Humana has a 52-week low of $163.11 and a 52-week high of $456.50. The stock has a market capitalization of $51.96 billion, a P/E ratio of 42.09, a P/E/G ratio of 2.67 and a beta of 0.65.

Humana (NYSE:HUM – Get Free Report) last posted its earnings results on Friday, November 6th. The insurance provider reported ($0.70) EPS for the quarter, beating the consensus estimate of ($1.00) by $0.30. The company had revenue of $41.16 billion during the quarter, compared to analyst estimates of $40.87 billion. Humana had a return on equity of 8.50% and a net margin of 0.81%. The business’s revenue was up 26.1% compared to the same quarter last year. During the same period in the prior year, the company earned $3.24 earnings per share. Humana has set its FY 2026 guidance at 9.500- EPS. As a group, sell-side analysts forecast that Humana will post 9.03 earnings per share for the current year.

Hedge Funds Weigh In On Humana

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. bought a new stake in Humana during the 2nd quarter valued at $4,138,160,000. Pzena Investment Management LLC acquired a new position in Humana during the 2nd quarter worth $1,749,014,000. Assenagon Asset Management S.A. grew its stake in shares of Humana by 20,126.8% in the third quarter. Assenagon Asset Management S.A. now owns 1,255,479 shares of the insurance provider’s stock worth $479,053,000 after purchasing an additional 1,249,272 shares in the last quarter. Legal & General Group Plc bought a new position in shares of Humana in the second quarter worth $329,760,000. Finally, Barrow Hanley Mewhinney & Strauss LLC bought a new position in shares of Humana in the second quarter worth $314,922,000. 92.38% of the stock is owned by institutional investors.

Humana Company Profile

(Get Free Report)

Humana Inc is a U.S. health and wellness company that provides health insurance and healthcare services. Its insurance offerings include Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid and employer-sponsored plans.

The company also provides care through CenterWell, its healthcare services brand, which includes primary care, home health and pharmacy services. Its insurance and care offerings are available in markets across the United States, with availability varying by product and location.

Humana was founded in 1961 as a nursing home company and later expanded into health insurance.